Trial Profile
Clinical Trials Insight: 700008828
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2008
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary) ; Ondansetron
- Indications Nausea; Nausea and vomiting; Vomiting
- Focus Pharmacokinetics
- 08 May 2008 NDA expected to be filed year end 2008.
- 24 Nov 2005 New trial record.